Finance

Results: 4249-4260 of 47998

PR Newswire associated0

Selective PPARα Modulator "K-808" (Pemafibrate) Granted "Breakthrough Therapy" Designation by the U.S. Food and Drug Administration (FDA) As a Treatment for Primary Biliary Cholangitis

Interactive Brokers Expands Access to Korean Equities with Launch of Nextrade ATS

Andersen Global Adds Depth to Tax and Global Mobility Capabilities in Germany

PR Newswire associated0

Shantha Biologics Announces Cartridge Fill-Finish Collaboration

New Human Study in Nature's Scientific Reports Finds Candela's Nordlys® Non-Ablative Fractional Laser Reverses the Skin's Epigenetic Signature of Aging

Human-Robot Collaboration Takes Center Stage at Prestigious Logistics Award

SC Therapeutics Initiates REACH2 Trial for Refractory Chronic Cough

Federico Invernizzi, Chief Operating Officer, Federico Mazzorin, Chief Scientist & Founder, Tommaso Migliore, CEO and Founder of MDOTM

MDOTM Raises $27M Growth Equity Round Led by Expedition Growth Capital as AI Adoption Permeates the Asset and Wealth Management Industry

PR Newswire associated0

Cumulus Neuroscience Announces Publication in Frontiers in Digital Health Demonstrating the NeuLogiq® Platform Is Feasible and Usable for At-Home Cognitive and EEG Assessment in People Living with Mild Alzheimer's Disease Dementia

Riskified Study: As AI Drives a Summer Travel Boom, Clunky Security and Scam Fears Threaten Merchant Conversions

Corpay Cross-Border Named the Official Global FX Partner of Fever

New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome